Is Neoleukin Therapeutics Stock Halal?

Key Points

  • After examining Neoleukin’s source of revenue, ratio of interest expense to total operating expense, and ESG impact we are comfortable investing in Neoleukin from a Halal perspective.

Company Overview

Neoleukin Therapeutics develops immunotherapies for cancer, inflammation, and autoimmune disorders using a proprietary protein design technology. All Neoleukin product candidates are in early clinical or preclinical development.

How much of Neoleukin Therapeutics Inc.’s revenue comes from haram?

The company has not generated product revenue or achieved profitability since its inception in 2003 and expects to continue to incur net losses for the foreseeable future. Neoleukin funds its operation through public or private equity or debt financings. As of December 31, 2021, the company had approximately $142.5 million in cash and cash equivalents, sufficient to sustain the company’s operation until the second half of 2023. Neoleukin expects a significant portion of its future revenue and cash resources from collaboration or similar agreements. 

Practical Islamic finance concludes

Neoleukin Therapeutics has no revenue source yet, and its business model is not inherently haram.

Does Neoleukin Therapeutics Inc. rely on interest to operate?

Fiscal Year ended 12/31/2021Fiscal Year ended 12/31/2020Fiscal Year ended 12/31/2019
Interest Expense000
Total Operating Expense60,69833,72870,959
Interest Expense / Total Operating Expense0.00%0.00%0.00%

*Numbers in thousands, of U.S. dollars 

Practical Islamic finance concludes:

Riba is not used in Neoleukin Therapeutics Inc.’s operations.

What is Neoleukin Therapeutics Inc.’s Environmental, Social, and Governance (ESG) impact?

Environment

Neoleukin uses sustainable building materials, implements energy-saving utility practices, and applies waste reduction measures in its laboratories and office facilities.

Social

Neoleukin Therapeutics has a Glassdoor rating of 4.5 out of 5.0. Glassdoor is a trusted website where current and former employees can review and rate their companies.

Governance

No notable governance highlights.

Practical Islamic finance concludes:

Neoleukin Therapeutics Inc. has a net positive ESG impact. 

Comfort Rating

From Neoleukin Therapeutics Inc. business, financial, and ESG reviews, Practical Islamic Finance rates Neoleukin Therapeutics Inc. stock as

Comfortable to invest in from a Halal perspective.

Sources

10K December 2021

10K December 2020

Neoleukin Glassdoor Review

Sign up for our newsletter and receive our “Beginner’s Guide to Halal Investing in Stocks” for FREE!

Enter your email address to subscribe:*